ECJ Action for annulment – Medicinal products for human use – Active substance eszopiclone – Marketing authorisation – Refusal of recognition as a new active substance – Act not amenable to review – Inadmissibility
ECLI:EU:T:2011:327, [2011] EUECJ T-275/09 – CO
Bailii
European
Commercial
Updated: 23 January 2022; Ref: scu.569576
